Celularity Inc. (CELU)
$1.42-3.40%Close
BUYCRISIS · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $41M
- Beta
- 0.54
- P/E (TTM)
- -0.50
- Short % float
- 2.07%
- Days to cover
- 2.5
- SI change
- -52.3%
- 1W
- -10.13%
- 1M
- +1.43%
- vs SPY 1W
- -9.99%
- vs SPY 1M
- -1.08%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 10
- VALUE
- 25
- GROWTH
- 35
- GARP
- 7
- TYPE
- Value / Recovery
Composite of Value · Growth · GARP
ROIC143.9%
REV YoY-
ROE239.8%
EPS YoY-
ROA-71.7%
GROSS80
OP-321
NET-376
[VALUATION]
P/E TTM-0.50
P/E FWD1.07
SECTOR PE20.34
INDUSTRY PE13.84
P/B-1.17
P/FCF-
EV/EBITDA-1.67
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.09
ND/EBITDA-
BETA0.54
Company news
FAQ
- What is LOPJLB’s current signal on CELU?
- LOPJLB’s latest quantitative signal on Celularity Inc. (CELU) is BUY in a CRISIS regime. Signals are updated daily.
- What market regime is CELU in?
- Celularity Inc. (CELU) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Celularity Inc. (CELU) do?
- Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The companyâs operations are segmented into three distinct ar…